SCHEMBL26873342

SCHEMBL26873342

CC(C)(c1cc(N)n2ncc(Cl)c2n1)C1CCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 13/20 0.36
▸ CCNA2 P20248 10/20 0.36
▸ CCNA1 P78396 10/20 0.36
▸ CCNT1 O60563 3/20 0.36
▸ CDK9 P50750 3/20 0.36
▸ CDK1 P06493 2/20 0.36
▸ CDK4 P11802 2/20 0.36
▸ CCND1 P24385 2/20 0.36
▸ CCNE1 P24864 2/20 0.36
▸ CDK7 P50613 2/20 0.36
▸ CCNH P51946 2/20 0.36
▸ CDK3 Q00526 2/20 0.36
▸ CDK6 Q00534 2/20 0.36
▸ CDK5 Q00535 2/20 0.36
▸ CDK5R1 Q15078 2/20 0.36
▸ CCNC P24863 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ CHEK1 O14757 9/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26873337 0.82 CDK2 (0.39) CDK2CCNA2CCNA1CCNT1CDK9
SCHEMBL26871082 0.81 CDK2 (0.36) CDK2CCNA2CCNA1CCNT1CDK9
SCHEMBL26868395 0.80 PIM1 (0.36) CDK2CCNA2CCNA1CHEK1KDM4E
SCHEMBL26868450 0.78 CDK2 (0.35) CDK2CCNA2CCNA1CHEK1KDM4E
SCHEMBL26868447 0.77 CHEK1 (0.51) CDK2CCNA2CCNA1CHEK1KDM4E
SCHEMBL26868448 0.77 CDK2 (0.37) CDK2CCNA2CCNA1CDK9CDK1
SCHEMBL26868396 0.77 PIM1 (0.38) CDK2CCNA2CCNA1CHEK1KDM4E
SCHEMBL26872835 0.77 CDK2 (0.46) CDK2CCNA2CCNA1CCNT1CDK9
SCHEMBL26871139 0.75 KDM4E (0.34) KDM4EMEN1ALDH1A1MAPTRAB9A
SCHEMBL26873554 0.75 KDM4E (0.36) CDK2CCNA2CCNA1CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback